Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
12 | 68808835 | intron variant | T/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
12 | 68808835 | intron variant | T/A | snv | 4.8E-02 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2012 | 2012 | |||||||||
|
12 | 68826856 | intron variant | C/T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68826856 | intron variant | C/T | snv | 0.29 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68839425 | missense variant | C/A;T | snv | 3.6E-05 | 7.0E-06 |
|
Neoplasms | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||||||
|
12 | 68847050 | 3 prime UTR variant | A/G | snv | 0.34 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
12 | 68816914 | missense variant | G/C | snv | 4.0E-06 |
|
Neoplasms | 0.010 | < 0.001 | 1 | 2019 | 2019 | |||||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.100 | 0.733 | 15 | 2007 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.100 | 0.900 | 10 | 2006 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2007 | 2019 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.050 | 1.000 | 5 | 2009 | 2014 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.050 | 0.800 | 5 | 2008 | 2017 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.040 | 1.000 | 4 | 2007 | 2019 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Respiratory Tract Diseases | 0.030 | 1.000 | 3 | 2008 | 2014 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Skin and Connective Tissue Diseases | 0.030 | 1.000 | 3 | 2010 | 2014 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Neoplasms; Nutritional and Metabolic Diseases | 0.020 | 1.000 | 2 | 2011 | 2016 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases | 0.020 | 0.500 | 2 | 2007 | 2011 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Digestive System Diseases; Neoplasms | 0.020 | 0.500 | 2 | 2011 | 2015 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Hemic and Lymphatic Diseases | 0.020 | 0.500 | 2 | 2012 | 2015 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms; Female Urogenital Diseases and Pregnancy Complications | 0.020 | 1.000 | 2 | 2013 | 2014 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2012 | 2013 | |||||||
|
0.550 | 0.720 | 12 | 68839311 | missense variant | C/G | snv | 4.0E-06 |
|
Neoplasms | 0.020 | 1.000 | 2 | 2009 | 2009 |